Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. In this article, we will take a closer look at hedge fund sentiment towards NGM Biopharmaceuticals, Inc. (NASDAQ:NGM). NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) shareholders have witnessed an increase in hedge fund interest of late.